GENDELL JEFFREY L - SEELOS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
GENDELL JEFFREY L ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,241,003
-79.9%
6,744,585
+30.5%
0.07%
-85.2%
Q2 2023$6,175,784
+76.3%
5,168,020
+2.0%
0.48%
+46.0%
Q1 2023$3,503,015
+5.1%
5,068,020
+3.2%
0.33%
+11.2%
Q4 2022$3,333,024
-34.1%
4,908,7250.0%0.30%
-55.4%
Q3 2022$5,056,000
+51.4%
4,908,7250.0%0.66%
+71.5%
Q2 2022$3,340,000
-19.2%
4,908,725
-0.5%
0.39%
+30.0%
Q1 2022$4,133,000
+3.5%
4,933,024
+101.4%
0.30%
-8.3%
Q4 2021$3,992,000
-10.9%
2,449,267
+31.7%
0.32%
-15.8%
Q3 2021$4,481,000
-2.6%
1,859,635
+6.7%
0.38%
-5.6%
Q2 2021$4,601,000
-24.7%
1,742,776
+42.2%
0.41%
-37.4%
Q1 2021$6,114,0001,225,2440.65%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders